Arcutis Biotherapeutics Dividend
Dividend criteria checks 0/6
Arcutis Biotherapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$2.27 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Arcutis Biotherapeutics: Betting Big On Zoryve
May 01New Forecasts: Here's What Analysts Think The Future Holds For Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Apr 25Need To Know: Analysts Are Much More Bullish On Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenues
Mar 03Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Just Reported Yearly Earnings And Analysts Are Lifting Their Estimates
Mar 02Arcutis Biotherapeutics, Inc.'s (NASDAQ:ARQT) 75% Share Price Surge Not Quite Adding Up
Feb 28Arcutis: Slow Sales Of Zoryve May Be Painting The Wrong Picture
Jan 31Growth Investors: Industry Analysts Just Upgraded Their Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenue Forecasts By 21%
Oct 23Analysts' Revenue Estimates For Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Are Surging Higher
Aug 13Earnings Release: Here's Why Analysts Cut Their Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Price Target To US$41.57
Aug 11Does Arcutis Biotherapeutics (NASDAQ:ARQT) Have A Healthy Balance Sheet?
May 02Is Arcutis Biotherapeutics (NASDAQ:ARQT) A Risky Investment?
Dec 18Arcutis sees positive top-line results from roflumilast in scalp and body psoriasis
Sep 26Arcutis Biotherapeutics: A Name To Accumulate
Sep 18Arcutis acquires privately-held biotech Ducentis BioTherapeutics
Sep 07Arcutis launches plaque psoriasis therapy Zoryve in US
Aug 10Is Arcutis Biotherapeutics (NASDAQ:ARQT) A Risky Investment?
Aug 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ARQT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ARQT's dividend payments have been increasing.
Dividend Yield vs Market
Arcutis Biotherapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (ARQT) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (ARQT) | 0% |
Notable Dividend: Unable to evaluate ARQT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ARQT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ARQT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ARQT has not reported any payouts.